Y-Clone Medical Sciences Inc. was founded in Suzhou in 2013. The company’s proprietary technology is capable of inducing difficult antibodies such as broadly neutralizing antibodies against V3 region of HIV. The company focuses on developing diagnostically and therapeutically effective antibodies and designed vaccines against infectious diseases. We have successfully developed a broadly neutralizing antibody against HIV and specific antibodies against HPV 16 and 18. This platform technology can be applied to many areas.

        The technology is open for licensing.